kapurimycin A3: structure given in first source; isolated from a Streptomyces sp. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 6438610 |
| MeSH ID | M0183551 |
| Synonym |
|---|
| 4h-anthra(1,2-b)pyran-5-acetic acid, 8-(acetyloxy)-8,9,10,11-tetraahydro-12-hydroxy-2-(2-methyl-3-(1-propenyl)oxiranyl)-4,11-dioxo- |
| kapurimycin a3 |
| 2-[(8s)-8-acetyloxy-12-hydroxy-2-[(2s,3r)-2-methyl-3-[(z)-prop-1-enyl]oxiran-2-yl]-4,11-dioxo-9,10-dihydro-8h-naphtho[2,3-h]chromen-5-yl]acetic acid |
| 129966-45-6 |
Kapurimycin A3 is a new antitumor antibiotic isolated from a Streptomyces.
| Excerpt | Reference | Relevance |
|---|---|---|
| "Kapurimycin A3 is a new antitumor antibiotic isolated from a Streptomyces. " | ( Covalent modification and single-strand scission of DNA by a new antitumor antibiotic kapurimycin A3. Hara, M; Nakano, H; Yoshida, M, 1990) | 1.95 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.37) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||